The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, August 26, 2020
Trishula Therapeutics was launched to be dedicated to the development of TTX-030, a first-in-class anti-CD39 antibody, being studied in advanced ...
read more
Thursday, August 27, 2020
JanOne has successfully completed its initial engineering batch of JAN101.
read more
RedHill Biopharma announced its U.S. Phase 2 study with opaganib in patients hospitalized with severe COVID-19 pneumonia, has successfully passed the...
read more
Hackensack Meridian Health is now enrolling individuals in a COVID-19 vaccine clinical trial.
read more
Provention Bio announced the initiation of the Phase 2b study of an anti-interleukin-15 monoclonal antibody, in adult celiac patients not responding ...
read more
Mylan and Biocon announced the U.S. launch of Semglee in vial and pre-filled pen presentations, approved to help control high blood sugar with type 1 ...
read more
Tuesday, September 01, 2020
Oncopeptides announced the FDA has granted priority review for Oncopeptides' NDA seeking approval of melflufen.
read more
Tuesday, September 01, 2020
Innovent Biologics announced the Phase I clinical study of recombinant anti-interleukin 23p19 subunit antibody injection has completed the first ...
read more
Tuesday, September 01, 2020
MediciNova announced development progress on its intranasal SARS-CoV-2 vaccine for COVID-19 utilizing BC-PIV, a viral vector platform technology ...
read more
Tuesday, September 01, 2020
Cartesian has initiated a trial of its lead RNA-engineered mesenchymal stem cell therapy, Descartes-30, in patients with moderate-to-severe ARDS, ...
read more
Wednesday, September 02, 2020
Gilead Sciences announced an agreement with Jounce Therapeutics to exclusively license its JTX-1811 program.
read more
Wednesday, September 02, 2020
AstraZeneca Pharmaceuticals
AZD1222 development expanded into a Phase III clinical trial in the US to assess its safety, efficacy and immunogenicity.
read more
Wednesday, September 02, 2020
Micron recently received a second tranche of funding to continue development of its microneedle-based technology for measles and rubella vaccination.
read more
Wednesday, September 02, 2020
The FDA approved azacitidine for continued treatment of patients with acute myeloid leukemia.
read more
Thursday, September 03, 2020
CenExel Centers of Excellence are participating in U.S. Operation Warp Speed projects to advance COVID-19 vaccine research quickly without sacrificing...
read more